The Role of Oxytocin in Regulating Blood Glucose

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Glucose Metabolism Disorders (Including Diabetes Mellitus)

In brief

Investigating the effect of oxytocin on pancreatic endocrine functions by determining insulin and glucagon secretion within physiological ranges of plasma glucose.

Key facts

Study ID

NCT06334172

Run by

University Hospital, Gentofte, Copenhagen

People needed

20

Starts

2024-01-01

Expected to finish

2026-12-31

Last updated by the study team

2024-04-04

Who can join

Age: 20 and older, up to 50. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• BMI 19-25 kg/m2

You may not qualify if…

• Diabetes
• Heart-, liver or kidney disease
• More than 14 units of alcohol weekly, or drug abuse
• Smoking or any kind of nicotine products
• Alanin aminotransferase (ALAT) ≥ 2 × normal range
• Estimated glomerular filtration rate (eGFR) < 60 ml/min/1,73m2 or creatinine above normal range
• Blood pressure > 140/90
• Hemoglobin < normal range
• Corrected QT Interval (Qtc) >0,45 sec. at electrocardiogram (ECG) at screening
• Known disease in the pituitary gland or previous pituitary surgery
• Any other disease/condition which the trial managers believe may affect participation in the trial

Where it is running

• Center for Clinical Metabolic Research, Gentofte Hospital — Hellerup, Capital Region, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.